• Strategic Technologies

Stevenage Bioscience Catalyst: First science park in the UK to adopt Warp It equipment reuse scheme

Stevenage Bioscience Catalyst is leading the way by introducing the Warp It recycling scheme. The online reuse platform will enable occupier companies to donate and receive lab and office equipment, supplies and furniture. This will reduce costs and carbon footprints for occupiers.

Member Spotlight: Interview with SPARTA Biodiscovery

We spoke with Jelle Penders, CEO, CTO and Founder of SPARTA Biodiscovery, an Imperial College London spin-out commercialising the SPARTA® (Single Particle Automated Raman Trapping Analysis) technology.

Brainomix and Bridge Biotherapeutics, Inc. partner to utilize Brainomix’ AI-powered e-ILD software

The partnership will focus on quantitative analysis of imaging data by Brainomix AI software (e-ILD) within the Phase 2 Study of novel autotaxin inhibitor, BBT-877, in idiopathic pulmonary fibrosis (IPF)

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has entered into a multi-project target discovery collaboration with Roche, one of the world's leading biotechnology companies. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. Further financial terms are not disclosed.

Member Spotlight: Interview with Amir Afshar, Co-Founder & Chief Product Officer of Shellworks

In light of Zero Waste Week (5-9 September), we spoke to Amir Afshar, Co-Founder & Chief Product Officer, Shellworks about what businesses and individuals can do to become more environmentally sustainable. He believes that true sustainability doesn’t mean compromise and can be functional and cost-effective.

CEO Update | 5 September 2022

BIA will be striking a positive and optimistic tone for our sector this autumn to counter the doom and gloom newspaper headlines promote. Isn’t our sector amazing? BIA companies are turning incredible science into life-changing and planet-saving products and services with incredible vigour. This is what makes me incredibly optimistic for the future – where our ecosystem is central to the economic growth of the nation and the solutions to many of the challenges of our age. In this blog, I’ll focus on some of the priority areas for BIA work this autumn and my approach to them.

Brainomix's AI software to be rolled out across Hungary’s entire national healthcare system to improve stroke care

Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care. Funded under the EU4Health programme, it is the first national tender of its kind where one stroke AI imaging platform will be deployed across an entire national healthcare system.

Member Spotlight: Interview with Anna Hoesel, Life Sciences Development Lead, EQUANS

In light of Zero Waste Week, which is taking place 5-9 September, we spoke to Anna Hoesel, Life Sciences Development Lead, EQUANS about how the life sciences and biotech industry can use its strengths to champion sustainability and Net Zero, embracing energy, digital and industrial transitions and setting the tone for what best practice looks like for other sectors.

EngBio Innovator Spotlight: Prokarium

UK companies are working across a diverse range of applications of engineering biology. Featured in the 'Power of Biology: The UK is engineering biology for global good' report, the following case study highlights Prokarium and gives additional insight into how this transformative technology can be used across healthcare, industry and agriculture. 

Transplant hope for minorities as researchers change kidney blood type

Kidney Research UK-funded researchers at the University of Cambridge have successfully altered the blood type on three deceased donor kidneys in a ground-breaking discovery that could have major implications for kidney patients. The project could increase the supply of kidneys available for transplant, particularly within ethnic minority groups who are less likely to be a match for the majority of donated kidneys.